Incidence and characterization of neurological adverse events among a retrospective cohort of patients receiving immune checkpoint inhibitors

被引：0
|
作者：
Hunting, John
Faucheux, Andrew T.
Elko, Catherine A.
Bloomer, Chance H.
Duckworth, Christopher
Khoury, Lara M.
Strauss, Josh
Olson, Eric
Petty, William J.
Lycan, Thomas William
机构：
[1] Wake Forest Baptist Med Ctr, Winston Salem, NC USA
[2] Wake Forest Univ, Sch Med, Winston Salem, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2655
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors
    Yang, Kaili
    Li, Jiarui
    Sun, Zhao
    Bai, Chunmei
    Zhao, Lin
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3907 - 3918
  • [32] CARDIAC IMMUNE-RELATED ADVERSE EVENTS IN LUNG CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Kumar, Sany
    Fowler, Cosmo
    Thota, Ajit K.
    Pastores, Stephen M.
    CHEST, 2023, 164 (04) : 363A - 363A
  • [33] Immune-related Adverse Events in Patients With Cancer Receiving Influenza Vaccination and Immune Checkpoint Inhibitors
    Groeneveld, Geert H.
    Wijn, Dirk H.
    Vollaard, Albert M.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1519 - 1519
  • [34] Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors
    Kaili Yang
    Jiarui Li
    Zhao Sun
    Chunmei Bai
    Lin Zhao
    Clinical and Experimental Medicine, 2023, 23 : 3907 - 3918
  • [35] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Abdel-Wahab, Noha
    Diab, Adi
    Yu, Robert K.
    Futreal, Andrew
    Criswell, Lindsey A.
    Tayar, Jean H.
    Dadu, Ramona
    Shannon, Vickie
    Shete, Sanjay S.
    Suarez-Almazor, Maria E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1939 - 1949
  • [36] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Noha Abdel-Wahab
    Adi Diab
    Robert K. Yu
    Andrew Futreal
    Lindsey A. Criswell
    Jean H. Tayar
    Ramona Dadu
    Vickie Shannon
    Sanjay S. Shete
    Maria E. Suarez-Almazor
    Cancer Immunology, Immunotherapy, 2021, 70 : 1939 - 1949
  • [37] Predictors of severity and onset timing of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a retrospective analysis
    Fang, Qimei
    Qian, Yan
    Xie, Zhaolu
    Zhao, Hongqiong
    Zheng, Yang
    Li, Di
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [38] RHEUMATIC IMMUNE RELATED ADVERSE EVENTS OF CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW OF 70 PATIENTS
    Lenfant, T.
    Calabrese, L.
    Calabrese, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 841 - 842
  • [39] Adverse Events of Immune Checkpoint Inhibitors
    Foller, S.
    Oppel-Heuchel, H.
    Fetter, I.
    Winkler, Y.
    Grimm, M. -O.
    UROLOGE, 2017, 56 (04): : 486 - 491
  • [40] Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
    Heilbroner, Samuel Peter
    Few, Reed
    Mueller, Judith
    Chalwa, Jitesh
    Charest, Francois
    Suryadevara, Somasekhar
    Kratt, Christine
    Gomez-Caminero, Andres
    Dreyfus, Brian
    Neilan, Tomas G.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
12345